Prestige Consumer Healthcare Inc

PBH is in an early Stage 1 consolidation following a terminal decline, and a recent Momentum Breakout signals initial stabilization and upside asymmetry. The repaired 9/21 EMA regime now offers support, and price is holding just above these EMAs with neutral overbought/oversold context. Medium-term bullish permission from the Stage 1 setup aligns with the Free Cash Flow + Buybacks strategy’s disciplined shallow-pullback entries, and short-term timing conditions favor immediate participation.

• ↑Generated $246M FCF in fiscal 26, enabling $75M Q2 buybacks and faster debt paydown.
• ↑Acquired Pillar 5 to enhance sterile eye-care manufacturing and stabilize supply chain.
• ↓Q4 revenue fell to $281.6M, down 5% YoY due to supply-chain issues.